Global Biomonitoring and Bioburden Testing Market Research Report 2023

Report ID: 1989514 | Published Date: Feb 2026 | No. of Page: 84 | Base Year: 2025 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Culture Media and Reagents Kit
        1.2.3 Instruments
        1.2.4 PCR (Polymerase Chain Reaction)
        1.2.5 Automated Microbial Identification Systems
        1.2.6 Microscope
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Biomonitoring and Bioburden Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Medical Devices Testing
        1.3.3 Monitoring of Manufacturing Process
        1.3.4 Environmental Monitoring
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Biomonitoring and Bioburden Testing Market Perspective (2017-2028)
    2.2 Biomonitoring and Bioburden Testing Growth Trends by Region
        2.2.1 Biomonitoring and Bioburden Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Biomonitoring and Bioburden Testing Historic Market Size by Region (2017-2022)
        2.2.3 Biomonitoring and Bioburden Testing Forecasted Market Size by Region (2023-2028)
    2.3 Biomonitoring and Bioburden Testing Market Dynamics
        2.3.1 Biomonitoring and Bioburden Testing Industry Trends
        2.3.2 Biomonitoring and Bioburden Testing Market Drivers
        2.3.3 Biomonitoring and Bioburden Testing Market Challenges
        2.3.4 Biomonitoring and Bioburden Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue
        3.1.1 Global Top Biomonitoring and Bioburden Testing Players by Revenue (2017-2022)
        3.1.2 Global Biomonitoring and Bioburden Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Biomonitoring and Bioburden Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biomonitoring and Bioburden Testing Revenue
    3.4 Global Biomonitoring and Bioburden Testing Market Concentration Ratio
        3.4.1 Global Biomonitoring and Bioburden Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biomonitoring and Bioburden Testing Revenue in 2021
    3.5 Biomonitoring and Bioburden Testing Key Players Head office and Area Served
    3.6 Key Players Biomonitoring and Bioburden Testing Product Solution and Service
    3.7 Date of Enter into Biomonitoring and Bioburden Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Biomonitoring and Bioburden Testing Breakdown Data by Type
    4.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Type (2017-2022)
    4.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2023-2028)
5 Biomonitoring and Bioburden Testing Breakdown Data by Application
    5.1 Global Biomonitoring and Bioburden Testing Historic Market Size by Application (2017-2022)
    5.2 Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Biomonitoring and Bioburden Testing Market Size (2017-2028)
    6.2 North America Biomonitoring and Bioburden Testing Market Size by Country (2017-2022)
    6.3 North America Biomonitoring and Bioburden Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Biomonitoring and Bioburden Testing Market Size (2017-2028)
    7.2 Europe Biomonitoring and Bioburden Testing Market Size by Country (2017-2022)
    7.3 Europe Biomonitoring and Bioburden Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Biomonitoring and Bioburden Testing Market Size (2017-2028)
    8.2 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Biomonitoring and Bioburden Testing Market Size (2017-2028)
    9.2 Latin America Biomonitoring and Bioburden Testing Market Size by Country (2017-2022)
    9.3 Latin America Biomonitoring and Bioburden Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Biomonitoring and Bioburden Testing Market Size (2017-2028)
    10.2 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Biomonitoring and Bioburden Testing Introduction
        11.1.4 Merck Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 STERIS Laboratories
        11.2.1 STERIS Laboratories Company Detail
        11.2.2 STERIS Laboratories Business Overview
        11.2.3 STERIS Laboratories Biomonitoring and Bioburden Testing Introduction
        11.2.4 STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.2.5 STERIS Laboratories Recent Development
    11.3 Charles River Laboratories International
        11.3.1 Charles River Laboratories International Company Detail
        11.3.2 Charles River Laboratories International Business Overview
        11.3.3 Charles River Laboratories International Biomonitoring and Bioburden Testing Introduction
        11.3.4 Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.3.5 Charles River Laboratories International Recent Development
    11.4 Lumex Instruments
        11.4.1 Lumex Instruments Company Detail
        11.4.2 Lumex Instruments Business Overview
        11.4.3 Lumex Instruments Biomonitoring and Bioburden Testing Introduction
        11.4.4 Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.4.5 Lumex Instruments Recent Development
    11.5 Pacific BioLabs
        11.5.1 Pacific BioLabs Company Detail
        11.5.2 Pacific BioLabs Business Overview
        11.5.3 Pacific BioLabs Biomonitoring and Bioburden Testing Introduction
        11.5.4 Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.5.5 Pacific BioLabs Recent Development
    11.6 Sigma-Aldrich
        11.6.1 Sigma-Aldrich Company Detail
        11.6.2 Sigma-Aldrich Business Overview
        11.6.3 Sigma-Aldrich Biomonitoring and Bioburden Testing Introduction
        11.6.4 Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.6.5 Sigma-Aldrich Recent Development
    11.7 WuXi AppTec
        11.7.1 WuXi AppTec Company Detail
        11.7.2 WuXi AppTec Business Overview
        11.7.3 WuXi AppTec Biomonitoring and Bioburden Testing Introduction
        11.7.4 WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.7.5 WuXi AppTec Recent Development
    11.8 Dynatec Labs
        11.8.1 Dynatec Labs Company Detail
        11.8.2 Dynatec Labs Business Overview
        11.8.3 Dynatec Labs Biomonitoring and Bioburden Testing Introduction
        11.8.4 Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.8.5 Dynatec Labs Recent Development
    11.9 Nelson Laboratories
        11.9.1 Nelson Laboratories Company Detail
        11.9.2 Nelson Laboratories Business Overview
        11.9.3 Nelson Laboratories Biomonitoring and Bioburden Testing Introduction
        11.9.4 Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2017-2022)
        11.9.5 Nelson Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Biomonitoring and Bioburden Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Culture Media and Reagents Kit
    Table 3. Key Players of Instruments
    Table 4. Key Players of PCR (Polymerase Chain Reaction)
    Table 5. Key Players of Automated Microbial Identification Systems
    Table 6. Key Players of Microscope
    Table 7. Key Players of Others
    Table 8. Global Biomonitoring and Bioburden Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Biomonitoring and Bioburden Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Biomonitoring and Bioburden Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Biomonitoring and Bioburden Testing Market Share by Region (2017-2022)
    Table 12. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Biomonitoring and Bioburden Testing Market Share by Region (2023-2028)
    Table 14. Biomonitoring and Bioburden Testing Market Trends
    Table 15. Biomonitoring and Bioburden Testing Market Drivers
    Table 16. Biomonitoring and Bioburden Testing Market Challenges
    Table 17. Biomonitoring and Bioburden Testing Market Restraints
    Table 18. Global Biomonitoring and Bioburden Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Biomonitoring and Bioburden Testing Market Share by Players (2017-2022)
    Table 20. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomonitoring and Bioburden Testing as of 2021)
    Table 21. Ranking of Global Top Biomonitoring and Bioburden Testing Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Biomonitoring and Bioburden Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Biomonitoring and Bioburden Testing Product Solution and Service
    Table 25. Date of Enter into Biomonitoring and Bioburden Testing Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Biomonitoring and Bioburden Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2017-2022)
    Table 29. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Biomonitoring and Bioburden Testing Revenue Market Share by Type (2023-2028)
    Table 31. Global Biomonitoring and Bioburden Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Biomonitoring and Bioburden Testing Revenue Market Share by Application (2017-2022)
    Table 33. Global Biomonitoring and Bioburden Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Biomonitoring and Bioburden Testing Revenue Market Share by Application (2023-2028)
    Table 35. North America Biomonitoring and Bioburden Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Biomonitoring and Bioburden Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Biomonitoring and Bioburden Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Biomonitoring and Bioburden Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Biomonitoring and Bioburden Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Biomonitoring and Bioburden Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Biomonitoring and Bioburden Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Biomonitoring and Bioburden Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Merck Company Detail
    Table 46. Merck Business Overview
    Table 47. Merck Biomonitoring and Bioburden Testing Product
    Table 48. Merck Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. STERIS Laboratories Company Detail
    Table 51. STERIS Laboratories Business Overview
    Table 52. STERIS Laboratories Biomonitoring and Bioburden Testing Product
    Table 53. STERIS Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 54. STERIS Laboratories Recent Development
    Table 55. Charles River Laboratories International Company Detail
    Table 56. Charles River Laboratories International Business Overview
    Table 57. Charles River Laboratories International Biomonitoring and Bioburden Testing Product
    Table 58. Charles River Laboratories International Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 59. Charles River Laboratories International Recent Development
    Table 60. Lumex Instruments Company Detail
    Table 61. Lumex Instruments Business Overview
    Table 62. Lumex Instruments Biomonitoring and Bioburden Testing Product
    Table 63. Lumex Instruments Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 64. Lumex Instruments Recent Development
    Table 65. Pacific BioLabs Company Detail
    Table 66. Pacific BioLabs Business Overview
    Table 67. Pacific BioLabs Biomonitoring and Bioburden Testing Product
    Table 68. Pacific BioLabs Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 69. Pacific BioLabs Recent Development
    Table 70. Sigma-Aldrich Company Detail
    Table 71. Sigma-Aldrich Business Overview
    Table 72. Sigma-Aldrich Biomonitoring and Bioburden Testing Product
    Table 73. Sigma-Aldrich Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 74. Sigma-Aldrich Recent Development
    Table 75. WuXi AppTec Company Detail
    Table 76. WuXi AppTec Business Overview
    Table 77. WuXi AppTec Biomonitoring and Bioburden Testing Product
    Table 78. WuXi AppTec Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 79. WuXi AppTec Recent Development
    Table 80. Dynatec Labs Company Detail
    Table 81. Dynatec Labs Business Overview
    Table 82. Dynatec Labs Biomonitoring and Bioburden Testing Product
    Table 83. Dynatec Labs Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 84. Dynatec Labs Recent Development
    Table 85. Nelson Laboratories Company Detail
    Table 86. Nelson Laboratories Business Overview
    Table 87. Nelson Laboratories Biomonitoring and Bioburden Testing Product
    Table 88. Nelson Laboratories Revenue in Biomonitoring and Bioburden Testing Business (2017-2022) & (US$ Million)
    Table 89. Nelson Laboratories Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biomonitoring and Bioburden Testing Market Share by Type: 2021 VS 2028
    Figure 2. Culture Media and Reagents Kit Features
    Figure 3. Instruments Features
    Figure 4. PCR (Polymerase Chain Reaction) Features
    Figure 5. Automated Microbial Identification Systems Features
    Figure 6. Microscope Features
    Figure 7. Others Features
    Figure 8. Global Biomonitoring and Bioburden Testing Market Share by Application in 2021 & 2028
    Figure 9. Medical Devices Testing Case Studies
    Figure 10. Monitoring of Manufacturing Process Case Studies
    Figure 11. Environmental Monitoring Case Studies
    Figure 12. Biomonitoring and Bioburden Testing Report Years Considered
    Figure 13. Global Biomonitoring and Bioburden Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Biomonitoring and Bioburden Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Biomonitoring and Bioburden Testing Market Share by Region: 2021 VS 2028
    Figure 16. Global Biomonitoring and Bioburden Testing Market Share by Players in 2021
    Figure 17. Global Top Biomonitoring and Bioburden Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomonitoring and Bioburden Testing as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Biomonitoring and Bioburden Testing Revenue in 2021
    Figure 19. North America Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Biomonitoring and Bioburden Testing Market Share by Country (2017-2028)
    Figure 21. United States Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Biomonitoring and Bioburden Testing Market Share by Country (2017-2028)
    Figure 25. Germany Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Biomonitoring and Bioburden Testing Market Share by Region (2017-2028)
    Figure 33. China Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Biomonitoring and Bioburden Testing Market Share by Country (2017-2028)
    Figure 41. Mexico Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Biomonitoring and Bioburden Testing Market Share by Country (2017-2028)
    Figure 45. Turkey Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Biomonitoring and Bioburden Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Merck Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 48. STERIS Laboratories Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 49. Charles River Laboratories International Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 50. Lumex Instruments Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 51. Pacific BioLabs Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 52. Sigma-Aldrich Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 53. WuXi AppTec Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 54. Dynatec Labs Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 55. Nelson Laboratories Revenue Growth Rate in Biomonitoring and Bioburden Testing Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
STERIS Laboratories
Charles River Laboratories International
Lumex Instruments
Pacific BioLabs
Sigma-Aldrich
WuXi AppTec
Dynatec Labs
Nelson Laboratories
Frequently Asked Questions
Biomonitoring and Bioburden Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biomonitoring and Bioburden Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biomonitoring and Bioburden Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports